| Literature DB >> 34017185 |
Jiaying Tan1, Mi Tian1, Feng Zhao1, Shuixiang Deng1, Peng Jin1, Yao Wang1, Huimei Wen1, Xiaohua Qin2,3, Ye Gong1,4.
Abstract
BACKGROUND: Male genitourinary abscess is one of the serious complications of urinary tract infections (UTIs). There were few researches on the clinical and pathogenic characteristics of male genitourinary abscess. PATIENTS AND METHODS: A retrospective observational study was conducted between January 2004 and April 2019. Male patients with genitourinary abscess originated from urinary tract, including sites of scrotum, testis, epididymis, spermatic cord, and prostate, were enrolled. Clinical and microbial records were collected and analyzed, and antimicrobial susceptibility testings were performed according to CLSI standard. Whole-genome sequencing was applied to detect the β-lactamase genes and virulence genes, as well as to determine the multilocus-sequence typing (MLST) of the collected Klebsiella pneumoniae (K. pneumoniae) isolates.Entities:
Keywords: MLST type; carbapenem-resistant Klebsiella pneumoniae; male genitourinary abscess; virulence genes
Year: 2021 PMID: 34017185 PMCID: PMC8131006 DOI: 10.2147/IDR.S298250
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1Flowchart of the study selection process.
Figure 2Case number of the male genitourinary abscess originated from urinary tract throughout the study period.
Characteristics of Patients Diagnosed with Male Genitourinary Abscess Originated from Urinary Tract
| Variables | |
|---|---|
| Age (years), mean (SD) | 54.5 (16.5) |
| Categories of abscess site, no. (%) | |
| Scrotum only | 14 (63.6) |
| Prostate only | 5 (22.7) |
| Both | 3 (13.6) |
| Comorbidities, no. (%) | |
| Post urogenital tract surgery | 4 (18.2) |
| Post transplantation | 1 (4.5) |
| Urogenital neoplasm | 1 (4.5) |
| Diabetes | 5 (22.7) |
| Liver cirrhosis | 1 (4.5) |
| Cerebrovascular diseases | 6 (27.3) |
| Trauma | 4 (18.2) |
| Pulmonary infection | 6 (27.3) |
| Intracranial infection | 2 (9.1) |
| Immunocompromised condition | 3 (13.6) |
| Clinical symptoms, no. (%) | |
| Urinary irritation | 5 (22.7) |
| Scrotal swelling | 15 (68.2) |
| Perineal symptoms | 1 (4.5) |
| Skin warmth | 13 (59.1) |
| Skin ulceration | 10 (45.5) |
| Local mass | 4 (18.2) |
| Fever | 19 (86.4) |
| Peak temperature (˚C), mean (SD) | 38.5 (1.1) |
| Indwelling invasive devices, no. (%) | |
| Central venous catheter/PICC | 5 (22.7) |
| Urinary tract catheter | 10 (45.5) |
| Severity, no. (%) | |
| Sepsis | 4 (18.2) |
| Septic shock | 2 (9.1) |
| Broad-spectrum antimicrobial treatment, no. (%) | 20 (90.9) |
| Surgical treatment, no. (%) | |
| Abscess drainage | 14 (63.6) |
| Orchiectomy/epididymectomy | 2 (9.1) |
| Length of hospital stay (days), median (IQR) | 16.5 (8–37) |
| Clinical outcomes, no. (%) | |
| Condition improvement | 20 (90.9) |
| Death | 2 (9.1) |
| 28-day mortality | 0 |
Abbreviation: PICC, peripherally inserted central catheter.
Results of Auxiliary Examination in Patients Diagnosed with Male Genitourinary Abscess Originated from Urinary Tract
| Auxiliary Examination | |
|---|---|
| Imaging or ultrasound positive features, no. (%) | |
| Imaging | 2 (10.5) |
| Ultrasound | 18 (94.7) |
| Blood test | |
| WBC ≥10×109/L, no. (%) | 16 (76.2) |
| WBC (×109/L), mean (SD) | 13.6 (5.6) |
| PCT >2 ng/mL, no. (%) | 4 (33.3) |
| Lactate >2 mmol/L, no. (%) | 2 (28.6) |
| Albumin <35g/L, no. (%) | 11 (50.0) |
| Prealbumin <200mg/L, no. (%) | 15 (71.4) |
| Urine test, no. (%) | |
| WBC increase | 16 (80.0) |
| RBC increase | 13 (65.0) |
| Bacterial count increase | 12 (60.0) |
Abbreviations: WBC, white blood cell; RBC, red blood cell; PCT, procalcitonin.
Results of Microbial Cultures in Patients Diagnosed with Male Genitourinary Abscess Originated from Urinary Tract
| Specimen | |
|---|---|
| Blood, no. (%) | |
| K. pneumoniae | 4 (18.2) |
| Brucella | 1 (4.5) |
| Staphylococcus | 1 (4.5) |
| Negative | 8 (36.4) |
| Unavailable | 8 (36.4) |
| Urine, no. (%) | |
| K. pneumoniae | 7 (31.8) |
| Staphylococcus | 1 (4.5) |
| Candida | 2 (9.1) |
| Negative | 4 (18.2) |
| Unavailable | 8 (36.4) |
| Pus, no. (%) | |
| K. pneumoniae | 7 (31.8) |
| Proteus mirabilis | 1 (4.5) |
| Negative | 1 (4.5) |
| Unavailable | 13 (59.1) |
Figure 3Heatmap of whole-genome sequencing.